Marketing-authorisation holder
Strides Pharma Intl
13 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
13 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACCOLATE10mg | 20mg · Tablet | Zafirlukast | United States | Marketed | 1996 |
| AMLODIPINE BESYLATE AND VALSARTAN10mg base; 160mg | 10mg base; 320mg | 5mg base; 160mg | 5mg base; 320mg · Tablet | Amlodipine, Valsartan | United States | Marketed | 2013 |
| AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE10mg base; 12.5mg; 160mg | 10mg base; 25mg; 160mg | 10mg base; 25mg; 320mg | 5mg base; 12.5mg; 160mg | 5mg base; 25mg; 160mg · Tablet | Amlodipine, Hydrochlorothiazide, Valsartan | United States | Marketed | 2012 |
| COLYTE3350 120GM/PACKET; 1.49GM/PACKET; 3.36GM/PACKET; 2.92GM/PACKET; 11.36GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3350 227.1GM/BOT; 2.82GM/BOT; 6.36GM/BOT; 5.53GM/BOT; 21.5GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3350 227.1GM/PAC · For solution | Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate anhydrous | United States | Not marketed | 1984 |
| COLYTE-FLAVORED3350 227.1GM/BOT; 2.82GM/BOT; 6.36GM/BOT; 5.53GM/BOT; 21.5GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3350 240GM/BOT; 2.98GM/BOT; 6.72GM/BOT; 5.84GM/BOT; 22.72GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solution | Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate anhydrous | United States | Not marketed | 1984 |
| COLYTE WITH FLAVOR PACKS3350 240gm/bot; 2.98gm/bot; 6.72gm/bot; 5.84gm/bot; 22.72gm/bot · For solution | Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate anhydrous | United States | Not marketed | 1984 |
| HYDRA-ZIDE100mg; 50mg | 25mg; 25mg | 50mg; 50mg · Capsule | Hydralazine, Hydrochlorothiazide | United States | Not marketed | 1985 |
| LYVISPAH10mg/packet | 20mg/packet | 5mg/packet · Granule | Baclofen | United States | Not marketed | 2021 |
| NILSTAT100% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Powder | Nystatin | United States | Not marketed | 1983 |
| PROPAFENONE HYDROCHLORIDE150mg | 225mg | 300mg · Tablet | Propafenone | United States | Marketed | 2000 |
| SUMYCIN100mg | 250mg | 500mg | 50mg · Tablet | Tetracycline | United States | Marketed | 1971 |
| TORSEMIDE100mg | 10mg | 20mg | 5mg · Tablet | Torasemide | United States | Marketed | 2002 |
| VOSPIRE ER4mg base | 8mg base · Tablet, extended release | Salbutamol | United States | Not marketed | 2002 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 13 | 13 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Strides Pharma Intl’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.